1. ANGI-08. EPIGENETIC REACTIVATION OF BAI1 SUPPRESSES TUMOR INVASION, RECURRENCE, AND SPINAL METASTASIS BY PREVENTING TGFΒ1-INDUCED MESENCHYMAL SWITCH IN GLIOBLASTOMA. (14th November 2022) Authors: Osuka, Satoru; Yang, Liquan; Hashimoto, Hideharu; Zhu, Dan; Zhang, Zhaobin; Olson, Jeffrey; Devi, Narra; Van Meir, Erwin Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ANGI-14. EPIGENETIC REACTIVATION OF BAI1 SUPPRESSES TUMOR INVASION BY PREVENTING TGFβ1-INDUCED MESENCHYMAL SWITCH IN GLIOBLASTOMA. (5th November 2018) Authors: Osuka, Satoru; Yang, Liquan; Zhu, Dan; Devi, Narra; Van Meir, Erwin Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Examining the structure-activity relationship of benzopyran-based inhibitors of the hypoxia inducible factor-1 pathway. Issue 8 (15th April 2017) Authors: Ferguson, Jalisa; De Los Santos, Zeus; Devi, Narra; Van Meir, Erwin; Zingales, Sarah; Wang, Binghe Journal: Bioorganic & medicinal chemistry letters Issue: Volume 27:Issue 8(2017) Page Start: 1731 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PDTM-12. ADGRB3 IS EPIGENETICALLY SILENCED IN WNT-MEDULLOBLASTOMA AND ITS REACTIVATION HAS THERAPEUTIC BENEFITS. (11th November 2019) Authors: Bhattacharya, Debanjan; Zhu, Dan; Osuka, Satoru; Kaluz, Stefan; Devi, Narra; Van Meir, Erwin Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗